Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy.

We investigated the hypothesis that patients developing high-grade erythema of the breast skin during radiation treatment could be more likely to present increased levels of proinflammatory cytokines which may lead, in turn, to associated fatigue. Forty women with early stage breast cancer who received adjuvant radiotherapy were enrolled from 2007 to 2010. Fatigue symptoms, erythema, and cytokine levels (IL-1β, IL-2, IL6, IL-8, TNF-α, and MCP-1) were registered at baseline, during treatment, and after radiotherapy completion.

Adjuvant chemoradiation with 5-fluorouracil or capecitabine in patients with gastric cancer after D2 nodal dissection.

Aim: To evaluate outcome and prognostic factors in patients with locally advanced gastric cancer.

Patients And Methods: From 2007 to 2011, 55 patients underwent adjuvant radiotherapy and concurrent chemotherapy with 5-fluorouracil (64%) or capecitabine (36%). D2 node resection was performed in all patients.

Hypofractionated radiotherapy with or without IGRT in prostate cancer: preliminary report of acute toxicity.

Background: To evaluate the acute tolerance to hypofractionated schedule of patients with prostate cancer.

Patients And Methods: We treated 62 patients with intermediate risk prostate cancer. All patients were treated with a total dose of 43.